Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches 2025-02-18 23:20
3Z Pharmaceuticals Unveils Landmark Study Supporting Calcium Channel Blocker as a Groundbreaking ADHD Therapy 2025-02-17 19:25
Vitafoods India 2025: Angel Yeast Brings Innovative Yeast Protein to Dining Table 2025-02-17 12:01
Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer 2025-02-17 08:00
Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region 2025-02-13 17:30
Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003 2025-02-13 13:18
Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium 2025-02-13 11:25
Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies 2025-02-13 10:30
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science 2025-02-13 06:00
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma 2025-02-12 09:00
Sustainable Leather Technology Advances With Collaboration Between Meatable and Pelagen 2025-02-11 20:04
Infinitus Secures Approval for National-Level Joint Laboratory Project, Ushering in a New Chapter of China-Europe Scientific Research Collaboration 2025-02-11 15:27
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China 2025-02-11 15:00
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S. 2025-02-06 19:40
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer 2025-02-06 14:05
Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances 2025-02-06 13:00
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) 2025-02-05 22:05
AI & Genomics Advances Bring New Hope to Lung Cancer Burden in Asia 2025-02-05 14:00
Aussie sleeptech firm unveils breakthrough test 2025-02-05 13:36
NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques 2025-02-05 06:48
1 27 28 29 30 31 264